Epsilon M&A Deal Report - Hameln Pharma
Transaction Multiples for the Valuation of Private Companies
Siegfried Holding / Hameln Pharma
No EMAT :
68219
Announced Date :
28/11/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Siegfried Holding
Target :
Hameln Pharma
Country :
Germany
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Hameln Pharma consists of the two companies Hameln Pharmaceuticals GmbH and Hameln Rds GmbH. Historically it goes back to the “Raths-Apotheke” in Hameln, family-owned since 1890. The company began...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns | ns | ns |
|
||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 17/07/2014 | Private Group led by Eurazeo PME | Colisée Patrimoine Group SAS (Les Jardins de Cybele) | France | *** | 68069 |
| 26/08/2014 | Medtronic | Sapiens Steering Brain Stimulation (Sapiens SBS) | Netherlands | * | 67979 |
Source: Epsilon Research / EMAT
